Whatever the demands of international regulators, it is public expectations that will ultimately dictate the need for life sciences companies to prepare complete and accurate product data that patients and healthcare providers can scrutinize on demand.
The deal is expected to close in the second half of 2020, but one analyst expects the transaction will raise antitrust issues in the United States.
The White House issued a statement on the president’s intent to nominate Hahn, who is currently the chief medical executive at The University of Texas MD Anderson Cancer Center in Houston.
The agency continues to monitor the safety of the grafts manufactured by Endologix, while the company defends its safety.
Six medical societies sent a letter to the agency over concern that limiting EtO sterilization will also limit the availability of certain devices to patients.
Namal Nawana had been in the role for less than two years.
Wireless medical applications have the potential to improve the quality of care, efficiency and patient comfort as well as reduce medical errors.
The total value of deals for 2019 exceeds $30 billion.
All of the issues that ECRI calls out on its list are preventable, so device manufacturers and healthcare providers should take serious note.
URGENT/11 introduces risks to medical device and hospital networks, and could allow a remote attacker to take control of a medical device such as an anesthesia machine of insulin pump.